HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

C-Reactive Protein

A plasma protein that circulates in increased amounts during inflammation and after tissue damage.
Also Known As:
C Reactive Protein; Protein, C-Reactive; Proteins, specific or class, C-reactive
Networked: 20245 relevant articles (442 outcomes, 2543 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Ridker, Paul M: 107 articles (09/2015 - 01/2002)
2. Rifai, Nader: 62 articles (01/2015 - 01/2002)
3. Tracy, Russell P: 56 articles (01/2016 - 02/2002)
4. Cushman, Mary: 50 articles (11/2015 - 12/2002)
5. Koenig, Wolfgang: 43 articles (08/2015 - 07/2002)
6. Stenvinkel, Peter: 41 articles (01/2016 - 11/2002)
7. Sattar, Naveed: 40 articles (09/2015 - 01/2002)
8. Lindholm, Bengt: 38 articles (01/2016 - 01/2002)
9. McMillan, Donald C: 38 articles (07/2015 - 01/2002)
10. Jialal, Ishwarlal: 38 articles (05/2014 - 02/2002)

Related Diseases

1. Inflammation
2. Infection
3. Pain (Aches)
06/01/2001 - "Both groups experienced a significant improvement in erythrocyte sedimentation rate, C reactive protein, Ritchie Articular Index, and pain score by 24 weeks (p<0.001, Friedman test). "
06/01/2000 - "All 10 corticosteroid treated patients responded to the first injection with a significant reduction in duration of morning stiffness, VAS pain scale, patient and physician global assessment, erythrocyte sedimentation rate, and C-reactive protein. "
10/12/1991 - "After four weeks at the health farm the diet group showed a significant improvement in number of tender joints, Ritchie's articular index, number of swollen joints, pain score, duration of morning stiffness, grip strength, erythrocyte sedimentation rate, C-reactive protein, white blood cell count, and a health assessment questionnaire score. "
09/01/2015 - "After 24 weeks of treatment, clinical features at baseline, including counts for tender joints and swelling joints, visual analog scale for pain, patient's and physician's global assessment, erythrocyte sedimentation rate, C-reactive protein, disease activity score 28, health assessment questionnaire, simplified disease activity index, and ACR50 in the MTX + T-614 group, showed statistically significant differences comparing with the MTX group (P < 0.05). "
06/19/2014 - "The coprimary end points at month 6 were the mean change from baseline in the van der Heijde modified total Sharp score (which ranges from 0 to 448, with higher scores indicating greater structural joint damage) and the proportion of patients with an American College of Rheumatology (ACR) 70 response (≥70% reduction in the number of both tender and swollen joints and ≥70% improvement in three of five other criteria: the patient's assessment of pain, level of disability, C-reactive protein level or erythrocyte sedimentation rate, global assessment of disease by the patient, and global assessment of disease by the physician). "
4. Insulin Resistance
5. Crohn Disease (Crohn's Disease)

Related Drugs and Biologics

1. Interleukin-6 (Interleukin 6)
2. Biological Markers (Surrogate Marker)
3. Fibrinogen (Factor I)
4. procalcitonin
5. Cholesterol
6. Insulin (Novolin)
7. Triglycerides (Triacylglycerol)
8. infliximab (Remicade)
9. Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
10. Adiponectin

Related Therapies and Procedures

1. Aftercare (After-Treatment)
2. Drug Therapy (Chemotherapy)
3. Bariatric Surgery
4. Transplants (Transplant)
5. Root Planing